Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis by the PDGFR/ROCK1 sign pathway
The targets of this research have been to analyze the position of the Notch1/PDGFRβ/ROCK1 signaling pathway within the pathogenesis of pulmonary fibrosis and to discover the opportunity of treating fibrosis by focusing on Notch1. Lung tissues from sufferers with pulmonary fibrosis have been examined for the expression of Notch1/PDGFRβ/ROCK1 utilizing RT-qPCR, western blotting, and immunostaining.
Cultured mouse lung pericytes have been transfected with Notch1-overexpressed vectors or shRNA focusing on PDGFRβ/ROCK1 to look at cell behaviors, together with proliferation, cell cycle arrest, and differentiation towards myofibroblasts.
Lastly, a mouse pulmonary fibrosis mannequin was ready, and a Notch1 inhibitor was administered to watch tissue morphology and pericyte cell behaviors. Human pulmonary fibrotic tissues offered with overexpression of Notch1, PDGFRβ, and ROCK1, along with a outstanding transition of pericytes into myofibroblasts.
In cultured mouse lung pericytes, overexpression of Notch1 led to the accelerated proliferation and differentiation of cells, and it additionally elevated the expression of the PDGFRβ and ROCK1 proteins. The knockdown of PDGFRβ/ROCK1 in pericytes remarkably suppressed pericyte proliferation and differentiation.
As additional substantiation, the administration of a Notch1 inhibitor in a mouse mannequin of lung fibrosis inhibited the PDGFRβ/ROCK1 pathway, suppressed pericyte proliferation and differentiation, and alleviated the severity of fibrosis.
Our outcomes confirmed that the Notch1 signaling pathway was aberrantly activated in pulmonary fibrosis, and this pathway could facilitate illness development by way of mediating pericyte proliferation and differentiation. The inhibition of the Notch1 pathway could present one promising remedy technique for pulmonary fibrosis.
Rat IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557817-100Tests | MyBiosource | 100Tests | EUR 175 |
Rat IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557817-200Tests | MyBiosource | 200Tests | EUR 235 |
Rat IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557817-20Tests | MyBiosource | 20Tests | EUR 115 |
Rat IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557817-5x200Tests | MyBiosource | 5x200Tests | EUR 1045 |
Rat IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557832-0025mg | MyBiosource | 0.025mg | EUR 115 |
Rat IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557832-01mg | MyBiosource | 0.1mg | EUR 175 |
Rat IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557832-5x01mg | MyBiosource | 5x0.1mg | EUR 785 |
Rat IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557886-0025mg | MyBiosource | 0.025mg | EUR 115 |
Rat IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557886-01mg | MyBiosource | 0.1mg | EUR 175 |
Rat IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557886-5x01mg | MyBiosource | 5x0.1mg | EUR 785 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557823-100Tests | MyBiosource | 100Tests | EUR 195 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557823-200Tests | MyBiosource | 200Tests | EUR 265 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557823-20Tests | MyBiosource | 20Tests | EUR 125 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557823-50Tests | MyBiosource | 50Tests | EUR 155 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557823-5x200Tests | MyBiosource | 5x200Tests | EUR 1115 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557838-0025mg | MyBiosource | 0.025mg | EUR 120 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557838-005mg | MyBiosource | 0.05mg | EUR 155 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557838-01mg | MyBiosource | 0.1mg | EUR 180 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557838-02mg | MyBiosource | 0.2mg | EUR 235 |
Rat IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557838-5x02mg | MyBiosource | 5x0.2mg | EUR 970 |
Rat IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557844-100Tests | MyBiosource | 100Tests | EUR 175 |
Rat IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557844-200Tests | MyBiosource | 200Tests | EUR 235 |
Rat IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557844-20Tests | MyBiosource | 20Tests | EUR 115 |
Rat IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557844-5x200Tests | MyBiosource | 5x200Tests | EUR 1045 |
Rat IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557859-0025mg | MyBiosource | 0.025mg | EUR 115 |
Rat IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557859-01mg | MyBiosource | 0.1mg | EUR 175 |
Rat IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557859-5x01mg | MyBiosource | 5x0.1mg | EUR 785 |
Rat IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557871-100Tests | MyBiosource | 100Tests | EUR 175 |
Rat IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557871-200Tests | MyBiosource | 200Tests | EUR 235 |
Rat IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557871-20Tests | MyBiosource | 20Tests | EUR 115 |
Rat IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557871-5x200Tests | MyBiosource | 5x200Tests | EUR 1045 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557892-0025mg | MyBiosource | 0.025mg | EUR 120 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557892-005mg | MyBiosource | 0.05mg | EUR 155 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557892-01mg | MyBiosource | 0.1mg | EUR 180 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557892-02mg | MyBiosource | 0.2mg | EUR 235 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557892-5x02mg | MyBiosource | 5x0.2mg | EUR 970 |
Mouse IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557736-100Tests | MyBiosource | 100Tests | EUR 175 |
Mouse IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557736-200Tests | MyBiosource | 200Tests | EUR 235 |
Mouse IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557736-20Tests | MyBiosource | 20Tests | EUR 115 |
Mouse IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557736-5x200Tests | MyBiosource | 5x200Tests | EUR 1045 |
Mouse IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557751-0025mg | MyBiosource | 0.025mg | EUR 115 |
Mouse IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557751-01mg | MyBiosource | 0.1mg | EUR 175 |
Mouse IgG1, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557751-5x01mg | MyBiosource | 5x0.1mg | EUR 785 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557850-100Tests | MyBiosource | 100Tests | EUR 195 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557850-200Tests | MyBiosource | 200Tests | EUR 265 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557850-20Tests | MyBiosource | 20Tests | EUR 125 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557850-50Tests | MyBiosource | 50Tests | EUR 155 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557850-5x200Tests | MyBiosource | 5x200Tests | EUR 1115 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557865-0025mg | MyBiosource | 0.025mg | EUR 120 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557865-005mg | MyBiosource | 0.05mg | EUR 155 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557865-01mg | MyBiosource | 0.1mg | EUR 180 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557865-02mg | MyBiosource | 0.2mg | EUR 235 |
Rat IgG2a, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557865-5x02mg | MyBiosource | 5x0.2mg | EUR 970 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557877-100Tests | MyBiosource | 100Tests | EUR 195 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557877-200Tests | MyBiosource | 200Tests | EUR 265 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557877-20Tests | MyBiosource | 20Tests | EUR 125 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557877-50Tests | MyBiosource | 50Tests | EUR 155 |
Rat IgG2b, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557877-5x200Tests | MyBiosource | 5x200Tests | EUR 1115 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557742-100Tests | MyBiosource | 100Tests | EUR 195 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557742-200Tests | MyBiosource | 200Tests | EUR 265 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557742-20Tests | MyBiosource | 20Tests | EUR 125 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557742-50Tests | MyBiosource | 50Tests | EUR 155 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557742-5x200Tests | MyBiosource | 5x200Tests | EUR 1115 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557757-0025mg | MyBiosource | 0.025mg | EUR 120 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557757-005mg | MyBiosource | 0.05mg | EUR 155 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557757-01mg | MyBiosource | 0.1mg | EUR 180 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557757-02mg | MyBiosource | 0.2mg | EUR 235 |
Mouse IgG1, kappa Isotype Control (APC/Cy7 Conjugated) |
|||
| MBS2557757-5x02mg | MyBiosource | 5x0.2mg | EUR 970 |
Mouse IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557763-100Tests | MyBiosource | 100Tests | EUR 175 |
Mouse IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557763-200Tests | MyBiosource | 200Tests | EUR 235 |
Mouse IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557763-20Tests | MyBiosource | 20Tests | EUR 115 |
Mouse IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557763-5x200Tests | MyBiosource | 5x200Tests | EUR 1045 |
Mouse IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557778-0025mg | MyBiosource | 0.025mg | EUR 115 |
Mouse IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557778-01mg | MyBiosource | 0.1mg | EUR 175 |
Mouse IgG2a, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557778-5x01mg | MyBiosource | 5x0.1mg | EUR 785 |
Mouse IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557790-100Tests | MyBiosource | 100Tests | EUR 175 |
Mouse IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557790-200Tests | MyBiosource | 200Tests | EUR 235 |
Mouse IgG2b, kappa Isotype Control (PE/Cy7 Conjugated) |
|||
| MBS2557790-20Tests | MyBiosource | 20Tests | EUR 115 |
PDGFR-induced autocrine SDF-1 signaling in most cancers cells promotes metastasis in superior pores and skin carcinoma.
Superior and undifferentiated pores and skin squamous cell carcinomas (SCCs) exhibit aggressive development and enhanced metastasis functionality, which is related in mice with an growth of the most cancers stem-like cell (CSC) inhabitants and with adjustments within the regulatory mechanisms that management the proliferation and invasion of those cells. Certainly, autocrine activation of PDGFRα induces CSC invasion and promotes distant metastasis in superior SCCs. Nevertheless, the mechanisms concerned on this course of have been unclear.
Right here, we present that CSCs of mouse superior SCCs (L-CSCs) specific CXCR4 and CXCR7, each receptors of SDF-1. PDGFRα signaling induces SDF-1 expression and secretion, and the autocrine activation of this pathway in L-CSCs.
Autocrine SDF-1/CXCR4 signaling induces L-CSC proliferation and survival, and mediates PDGFRα-induced invasion, selling in vivo lung metastasis. Validation of those findings in affected person samples of pores and skin SCCs exhibits a powerful correlation between the expression of SDF1, PDGFRA, and PDGFRB, which is upregulated, alongside CXCR4 in tumor cells of superior SCCs.
Moreover, PDGFR regulates SDF-1 expression and inhibition of SDF-1/CXCR4 and PDGFR pathways blocks distant metastasis of human PD/S-SCCs. Our outcomes point out that purposeful crosstalk between PDGFR/SDF-1 signaling regulates tumor cell invasion and metastasis in human and mouse superior SCCs, and recommend that CXCR4 and/or PDGFR inhibitors might be used to dam metastasis of those aggressive tumors.
Corrigendum Antiproliferative results of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell strains by way of PDGFR‑β, PDGF‑BB, c‑Package and SCF expression.
- An reader drew to our consideration that the above research appeared to comprise a excessive stage of overlap with an article by the identical authors revealed within the journal Drug Design, Improvement and Remedy [Kadivar A, Kamalidehghan B, Akbari Javar H, Karimi B, Sedghi R and Noordin MI: Antiproliferation effect of imatinib mesylate on MCF7, T‑47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF genes. Drug Des Devel Ther 11: 469‑481, 2017].
- Following an inside investigation and likewise in liaison with the authors, it was established that, though the research have been performed alongside broadly comparable strains, the papers contained fully totally different knowledge involving two totally different subsets of cell strains; the submission to Drug Des Devel Ther aimed to discover the results of imatinib mesylate on three totally different teams, with every group being represented by a cell line, whereas the submission to Int J Mol Med explored the effectiveness of imatinib mesylate in breast most cancers cell strains.
- Regardless of this, contemplating the relatedness of the articles and the truth that the paper to Drug Des Devel Ther was submitted first and revealed whereas the Int J Mol Med paper was passing by the peer‑evaluation course of, the authors concede that they need to have correctly referenced their paper submitted to Drug Des Devel Ther within the Int J Mol Med paper.
- Notice that the publishers of Drug Des Devel Ther, with whom we have been liaising, agreed with the choice to concern a Corrigendum for this paper that acknowledges the article revealed in Drug Des Devel Ther.
- The authors remorse their failure to acknowledge the associated paper on this occasion, and apologize to the readership for this oversight. [the original article was published in International Journal of Molecular Medicine 14: 414‑424, 2018; DOI: 10.3892/ijmm.2018.3590].
MYH Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460724-01mL | MyBiosource | 0.1mL | EUR 595 |
MYH Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460724-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
IDO Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460734-01mL | MyBiosource | 0.1mL | EUR 595 |
IDO Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460734-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
LDL Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460964-01mL | MyBiosource | 0.1mL | EUR 595 |
LDL Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460964-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
VWF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461509-01mL | MyBiosource | 0.1mL | EUR 595 |
VWF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461509-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
AXL Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461583-01mL | MyBiosource | 0.1mL | EUR 595 |
AXL Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461583-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
LHR Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461707-01mL | MyBiosource | 0.1mL | EUR 595 |
LHR Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461707-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
VWF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9462247-01mL | MyBiosource | 0.1mL | EUR 595 |
VWF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9462247-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD8 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9462541-01mL | MyBiosource | 0.1mL | EUR 595 |
CD8 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9462541-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
TrkB Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459795-01mL | MyBiosource | 0.1mL | EUR 595 |
TrkB Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459795-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
GFAP Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459808-01mL | MyBiosource | 0.1mL | EUR 595 |
GFAP Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459808-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
bFGF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459817-01mL | MyBiosource | 0.1mL | EUR 595 |
bFGF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459817-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD31 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459908-01mL | MyBiosource | 0.1mL | EUR 595 |
CD31 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459908-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD44 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459925-01mL | MyBiosource | 0.1mL | EUR 595 |
CD44 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459925-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD45 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459930-01mL | MyBiosource | 0.1mL | EUR 595 |
CD45 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459930-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD10 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459935-01mL | MyBiosource | 0.1mL | EUR 595 |
CD10 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459935-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD34 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459968-01mL | MyBiosource | 0.1mL | EUR 595 |
CD34 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459968-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD68 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459979-01mL | MyBiosource | 0.1mL | EUR 595 |
CD68 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9459979-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
PCNA Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460034-01mL | MyBiosource | 0.1mL | EUR 595 |
PCNA Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460034-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD56 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460057-01mL | MyBiosource | 0.1mL | EUR 595 |
CD56 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460057-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
ACE2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460156-01mL | MyBiosource | 0.1mL | EUR 595 |
ACE2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460156-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
SOD1 Polyclonal antibody Cy5 Conjugated |
|||
| MBS9460192-01mL | MyBiosource | 0.1mL | EUR 595 |
SOD1 Polyclonal antibody Cy5 Conjugated |
|||
| MBS9460192-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
SV2C Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460359-01mL | MyBiosource | 0.1mL | EUR 595 |
SV2C Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460359-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD14 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460444-01mL | MyBiosource | 0.1mL | EUR 595 |
CD14 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460444-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD68 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460660-01mL | MyBiosource | 0.1mL | EUR 595 |
CD68 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460660-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
PAFR Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460677-01mL | MyBiosource | 0.1mL | EUR 595 |
PAFR Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460677-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
DRD3 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460803-01mL | MyBiosource | 0.1mL | EUR 595 |
DRD3 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460803-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
P2Y4 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460828-01mL | MyBiosource | 0.1mL | EUR 595 |
P2Y4 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460828-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
TRF2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460843-01mL | MyBiosource | 0.1mL | EUR 595 |
TRF2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460843-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
Nkx2.5 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460907-01mL | MyBiosource | 0.1mL | EUR 595 |
Nkx2.5 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9460907-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
LMP2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461178-01mL | MyBiosource | 0.1mL | EUR 595 |
LMP2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461178-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
GGT1 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461217-01mL | MyBiosource | 0.1mL | EUR 595 |
GGT1 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461217-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
IRF3 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461220-01mL | MyBiosource | 0.1mL | EUR 595 |
IRF3 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461220-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
AQP2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461481-01mL | MyBiosource | 0.1mL | EUR 595 |
AQP2 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461481-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD45 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461525-01mL | MyBiosource | 0.1mL | EUR 595 |
CD45 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461525-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD44 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461548-01mL | MyBiosource | 0.1mL | EUR 595 |
CD44 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461548-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
BDNF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461566-01mL | MyBiosource | 0.1mL | EUR 595 |
BDNF Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461566-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
EMR1 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461799-01mL | MyBiosource | 0.1mL | EUR 595 |
EMR1 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461799-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
NIMP Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461874-01mL | MyBiosource | 0.1mL | EUR 595 |
NIMP Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461874-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD34 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461928-01mL | MyBiosource | 0.1mL | EUR 595 |
CD34 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461928-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
FECH Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461971-01mL | MyBiosource | 0.1mL | EUR 595 |
FECH Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461971-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
MYH7 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461990-01mL | MyBiosource | 0.1mL | EUR 595 |
MYH7 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9461990-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
CD31 Polyclonal Antibody Cy5 Conjugated |
|||
| MBS9462113-01mL | MyBiosource | 0.1mL | EUR 595 |
